密爾克衞(603713.SH):完成設立山東密爾克衞
格隆匯11月18日丨密爾克衞(603713.SH)公佈,公司全資子公司密爾克衞化工供應鏈服務控股有限公司擬全資設立山東密爾克衞供應鏈管理服務有限公司(以下簡稱“山東密爾克衞”)。
11月18日,山東密爾克衞完成了相關的工商變更登記手續,並取得了由煙台經濟技術開發區行政審批服務局下發的《營業執照》,經營範圍包括供應鏈管理,承辦海運、公路、航空、鐵路進出口貨物的國際及國內運輸代理業務,攬貨、訂艙、倉儲(不含危險品)、貨物中轉、集裝箱拼裝拆箱、報關、報驗及諮詢業務,民用航空運輸銷售代理,從事代理報關業務,商務信息諮詢(不含投資諮詢),集裝箱銷售、租賃、維修,機電設備租賃,道路運輸裝卸,企業管理諮詢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.